Mary do

Mary Do is a seasoned professional in the field of immunology, with a PhD from the University of California, Davis, and a BA in Biology from the University of California, Santa Cruz. Mary serves as a Senior Scientist at pH Pharma Co., Ltd., where responsibilities include leading projects on antibody development and validation. Previous experience includes a Scientist role at Oxford Biotherapeutics, focusing on ADC and bispecific antibodies, as well as postdoctoral research at Stanford University examining breast cancer cell populations. Additional roles at UC Davis, Medarex Inc., StemCells, Inc., and Signature BioScience Inc. have contributed to a robust expertise in biological assays and cancer research.